Literature DB >> 2444553

Proton relaxation times in bleomycin-induced lung injury.

C R Taylor1, H D Sostman, J C Gore, G W Smith.   

Abstract

Pulmonary fibrosis and inflammation induced in mice by biweekly injection of low doses (20 mg/kg) of bleomycin chronically administered subcutaneously was associated with a significant increase in T2 values measured in vitro (54.6 +/- 20.7 ms vs. 36.2 +/- 3.8 ms in controls). T1 values, however, were not altered significantly (613 +/- 124.6 ms vs. 666 +/- 105.7 ms in controls). Lung water content did not change (79.1 +/- 2.5% vs. 78.4 +/- 0.98% in controls, NS). Water content to dry weight ratio in the control group (3.63 +/- 0.212) did not differ significantly from that in the experimental group clinically treated with bleomycin (3.84 +/- .618). However, morphometric and histologic analysis indicated that in 71% of the chronically treated mice, there was marked pulmonary fibrosis (mean area of involvement 3.5 +/- 8.1% vs. 0.25 +/- 0.15% in controls, P less than .01). In addition, there was marked increase in pulmonary cellularity and infiltration by lymphocytes and macrophages (mean area of macrophage infiltration 8.71 +/- 13.256% vs. 1.17 +/- 1.404% in controls). The alteration in T2 in bleomycin damaged lung occurred in the absence of change in overall water content. However, the change in cellularity indicates an alteration of water distribution between the cellular, intravascular, and interstitial components induced by the measurable fibrotic and inflammatory response to bleomycin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2444553     DOI: 10.1097/00004424-198708000-00001

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  4 in total

1.  Direct leukocyte migration across pulmonary arterioles and venules into the perivascular interstitium of murine lungs during bleomycin injury and repair.

Authors:  Ping M Wang; Diane L Kachel; Mark F Cesta; William J Martin
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

Review 2.  Noninvasive imaging of experimental lung fibrosis.

Authors:  Yong Zhou; Huaping Chen; Namasivayam Ambalavanan; Gang Liu; Veena B Antony; Qiang Ding; Hrudaya Nath; Janet F Eary; Victor J Thannickal
Journal:  Am J Respir Cell Mol Biol       Date:  2015-07       Impact factor: 6.914

Review 3.  [T1 maps and O2-enhanced MRT of the diseased lung. Emphysema, fibrosis, mucoviscidosis].

Authors:  A Stadler; L Stiebellehner; P M Jakob; J F T Arnold; A A Bankier
Journal:  Radiologe       Date:  2006-04       Impact factor: 0.635

4.  Quantitative and o(2) enhanced MRI of the pathologic lung: findings in emphysema, fibrosis, and cystic fibrosis.

Authors:  Alfred Stadler; Leopold Stiebellehner; Peter M Jakob; Johannes F T Arnold; Edith Eisenhuber; Isabella von Katzler; Alexander A Bankier
Journal:  Int J Biomed Imaging       Date:  2007
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.